A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia
| Autor: | Jarskog, L. Fredrik, Pedersen, Cort A., Johnson, Jacqueline L., Hamer, Robert M., Rau, Shane W., Elliott, Tonya, Penn, David L. |
|---|---|
| Zdroj: | In Schizophrenia Research July 2017 185:88-95 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect